MVP facilitates the nuclear tumour-suppressing function of PTEN in a Ca2+ dependent manner [41]; nuclear PTEN is unable to inhibit PI3K signalling, leading to a more malignant phenotype [42]. The gene discussed is MVP; the disease is neoplasm.